Guillaume Bonnier

Guillaume Bonnier

Auto-generated profile, based on publicly available information

Guillaume Bonnier

Martinos Center for Biomedical Imaging Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GBGuillaume Bonnier
Guillaume Bonnier
ARAlexis Roche
Alexis Roche
DRDavid Romascano
David Romascano
SSSamanta Simioni
Samanta Simioni
DMDjalel Eddine Meskaldji
Djalel Eddine Meskaldji
CGCristina Granziera
Cristina Granziera
Introduction. Local microstructural pathology in multiple sclerosis patients might influence their clinical performance. This study applied multicontrast MRI to quantify inflammation and neurodegeneration in MS lesions. We explored the impact of MRI-based lesion pathology in cognition and disability.Methods. 36 relapsing-remitting MS subjects and 18 healthy controls underwent neurological, cognitive, behavioural examinations and 3 T MRI including (i) fluid attenuated inversion recovery, double inversion recovery, and magnetization-prepared gradient echo for lesion count; (ii) T1, T2, and T2*relaxometry and magnetisation transfer imaging for lesion tissue characterization. Lesions were classified according to the extent of inflammation/neurodegeneration. A generalized linear model assessed the contribution of lesion groups to clinical performances.Results. Four lesion groups were identified and characterized by (1) absence of significant alterations, (2) prevalent inflammation, (3) concomitant inflammation and microdegeneration, and (4) prevalent tissue loss. Groups 1, 3, 4 correlated with general disability (Adj-R2=0.6;P=0.0005), executive function (Adj-R2=0.5;P=0.004), verbal memory (Adj-R2=0.4;P=0.02), and attention (Adj-R2=0.5;P=0.002).Conclusion. Multicontrast MRI provides a new approach to inferin vivohistopathology of plaques. Our results support evidence that neurodegeneration is the major determinant of patients’ disability and cognitive dysfunction.

16 August 2016 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
MWMaryna Waszak
Maryna Waszak
PFPavel Falkovskiy
Pavel Falkovskiy
THTom Hilbert
Tom Hilbert
GBGuillaume Bonnier
Guillaume Bonnier
BMBénédi Maréchal
Bénédi Maréchal
GKGunnar Krueger
Gunnar Krueger
Purpose We suggest a motion correction concept that employs free‐induction‐decay (FID) navigator signals to continuously monitor motion and to guide the acquisition of image navigators for prospective motion correction following motion detection. Methods Motion causes out‐of‐range signal changes in FID time series that, and in this approach, initiate the acquisition of an image navigator. Co‐registration of the image navigator to a reference provides rigid‐body‐motion parameters to facilitate prospective motion correction. Both FID and image navigator are integrated into a prototype magnetization‐prepared rapid gradient‐echo (MPRAGE) sequence. The performance of the method is investigated using image quality metrics and the consistency of brain volume measurements. Results Ten healthy subjects were scanned (a) while performing head movements (nodding, shaking, and moving in z‐direction) and (b) to assess the co‐registration performance. Mean absolute errors of 0.27 ± 0.38 mm and 0.19 ± 0.24° for translation and rotation parameters were measured. Image quality was qualitatively improved after correction. Significant improvements were observed in automated image quality measures and for most quantitative brain volume computations after correction. Conclusion The presented method provides high sensitivity to detect head motion while minimizing the time invested in acquiring navigator images. Limits of this implementation arise from temporal resolution to detect motion, false‐positive alarms, and registration accuracy. Magn Reson Med 78:193–203, 2017. © 2016 International Society for Magnetic Resonance in Medicine

4 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GBGuillaume Bonnier
Guillaume Bonnier
TKTobias Kober
Tobias Kober
MSMyriam Schluep
Myriam Schluep
RPRenaud Du Pasquier
Renaud Du Pasquier
GKGunnar Krueger
Gunnar Krueger
ARAlexis Roche
Alexis Roche
The existence of partial volume effects in brain MR images makes it challenging to understand physio-pathological alterations underlying signal changes due to pathology across groups of healthy subjects and patients. In this study, we implement a new approach to disentangle gray and white matter alterations in the thalamus and the basal ganglia. The proposed method was applied to a cohort of early multiple sclerosis (MS) patients and healthy subjects to evaluate tissue-specific alterations related to diffuse inflammatory or neurodegenerative processes. Forty-three relapsing-remitting MS patients and nineteen healthy controls underwent 3T MRI including: (i) fluid-attenuated inversion recovery, double inversion recovery, magnetization-prepared gradient echo for lesion count, and (ii) T1 relaxometry. We applied a partial volume estimation algorithm to T1 relaxometry maps to gray and white matter local concentrations as well as T1 values characteristic of gray and white matter in the thalamus and the basal ganglia. Statistical tests were performed to compare groups in terms of both global T1 values, tissue characteristic T1 values, and tissue concentrations. Significant increases in global T1 values were observed in the thalamus (p = 0.038) and the putamen (p = 0.026) in RRMS patients compared to HC. In the Thalamus, the T1 increase was associated with a significant increase in gray matter characteristic T1 (p = 0.0016) with no significant effect in white matter. The presented methodology provides additional information to standard MR signal averaging approaches that holds promise to identify the presence and nature of diffuse pathology in neuro-inflammatory and neurodegenerative diseases.

14 August 2021 in European Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EFElda Fischi‐Gomez
Elda Fischi‐Gomez
GBGuillaume Bonnier
Guillaume Bonnier
NWNoreen Ward
Noreen Ward
CGCristina Granziera
Cristina Granziera
NHNouchine Hadjikhani
Nouchine Hadjikhani
There are currently no biomarkers for autism spectrum disorder (ASD). This neurodevelopmental condition has previously been associated with histopathological findings, including increased neuronal packing density in the amygdala, abnormal laminar cytoarchitecture and increased average neuronal density in the prefrontal cortex. The present study examined whether new brain imaging technologies could reveal in vivo, in adults with ASD, the manifestation of previously described histopathological changes. Using quantitative mapping at ultrahigh field (7 Tesla), we show that we can observe microstructural alterations in the right lateral orbitofrontal cortex and the bilateral amygdala in adult individuals with ASD in vivo. These imaging alterations point to an abnormal laminar cytoarchitecture and to an increased neuronal density, similar to what has been previously described in post‐mortem data in ASD. Our data demonstrate that it is possible to visualize, in vivo and at the individual level, alterations of cortical and subcortical microstructure in ASD. Future studies will be needed to extend these findings to a larger group of individuals and evaluate their association with symptomatology as well as their specificity among the different neurodevelopmental disorders.